DiviDrip · GNPX

GNPX — Genprex, Inc.

GNPX is Genprex, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.49. Market cap: $3M. Capital Quality Rank: 20/100 — Capital destroyer.

Stock snapshot

Price$3.49
Market cap$3M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)20 / 100 · Capital destroyer
ROIC (TTM)-3670.1%
Shareholder buyback yield-5.00%
Altman Z-score zoneDistress

About GNPX

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Listed2018Employees13HQAustin, TXSectorHealthcareWebsitegenprex.com

Related non-dividend companies

Other non-dividend stocks investors research alongside GNPX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is GNPX's current stock price?

GNPX (Genprex, Inc.) is currently trading at $3.49.

Does GNPX pay a dividend?

GNPX (Genprex, Inc.) does not currently pay a regular dividend.

What is GNPX's Capital Quality Rank?

GNPX has a Capital Quality Rank of 20/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track GNPX in DiviDrip

Add GNPX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow